Biotechnology
SureScripts, the nation's largest network provider of electronic prescribing services, today announced that Bruce Fried, Esq., Mark Frisse, M.D., and John Glaser, Ph.D., were elected by SureScripts' charter members as the first independent directors to i
03:05 May 24, 2006
Swiss Medica, Inc. today announced that TVA Productions of Studio City, California has started its major media campaign supporting Swiss Medica's O24 Fibromyalgia brand building across the United States. The 'MediaBlitz' campaign to be conducted by TVA P
03:05 May 24, 2006
On June 8 at 6 p.m. CDT Trinity Mother Frances Health System's Center For Advanced Surgery And Technology and OR-Live will host a live Webcast of a robotic-assisted prostatectomy. The broadcast will feature Andrew Kirkpatrick, MD, director of Trinity Mot
02:25 May 24, 2006
AtheroGenics, Inc. , a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today named Brian Blakey, Pharm.D. to the newly created position of Vice President of Marketing. Dr. Blakey will report directly to Mark P. Colonnese
02:05 May 24, 2006
Roche and Entelos, Inc. today announced a two-year collaboration in metabolic disease research. Under the terms of the agreement, Roche will provide R&D funding and milestone payments, and Entelos will conduct biosimulation research using its Metabol
02:05 May 24, 2006
Kiwa Bio-Tech Products Group Corporation announced that customers are performing 'application tests' of its bio-fertilizer products this summer.
20:02 May 23, 2006
Inflazyme Pharmaceuticals Ltd. today reported its financial results for the fourth quarter and year ended March 31, 2006.
16:35 May 23, 2006
The Parenteral Drug Association last week completed the second phase of GMP training for representatives from the Republic of Kazakhstan's Ministry of Health to develop a stronger, more informed pharmaceutical regulatory agency.
09:55 May 23, 2006
Amarillo Biosciences, Inc. today announced submission to the FDA of a protocol for a Phase II study to test low-dose interferon alpha lozenges administered orally to human immunodeficiency virus -positive subjects with oral warts. Viral lesions of the mo
07:45 May 23, 2006
Curative Health Services, Inc. today announced that the United States Bankruptcy Court for the Southern District of New York has confirmed the Company's prepackaged plan of reorganization that will eliminate the Company's $185 million debt obligation und
07:05 May 23, 2006
TOPIGEN Pharmaceuticals Inc., an emerging biopharmaceutical company specializing in respiratory disorders, today announced it has initiated a Phase II clinical trial of TPI-1020 in asthmatic smokers. This study is part of an overall clinical plan for the
07:05 May 23, 2006
Bioxel Pharma Inc. , a leading manufacturer of taxane active pharmaceutical ingredients and developer of targeted oncology drugs, is pleased to announce that it has entered into two separate letters of intent with companies specialized in pharmaceutical
06:55 May 23, 2006
Viropro Inc. , a company constantly solidifying its reputation as an international expert in the production and set-up of technology transfers of therapeutic proteins to pharmaceutical companies for the treatment of diseases such as cancer, diabetes, hep
05:02 May 23, 2006
ALR Technologies, Inc. is pleased to announce that informedHEALTH, LLC, based in Charlotte, NC, plans a third quarter launch of the ALRT500 Medication Compliance Reminder and Home Health monitoring system to be used along with early disease detection for
04:35 May 23, 2006
Biogenerics Limited announces it has entered into a Letter of Intent to purchase the assets, operations and all oil/gas leases from an East Texas operator and drilling company which has been in the oil industry for over 30 years. The agreement is expecte
04:02 May 23, 2006
19601 - 19615 of 23420 Stories
<<
<
Next 15 Biotechnology
>
>>